PMID
Data
Article Title
Organization
Discovery of N-Substituted (2-Phenylcyclopropyl)methylamines as Functionally Selective Serotonin 2C Receptor Agonists for Potential Use as Antipsychotic Medications.

University of Illinois At Chicago
Further Advances in Optimizing (2-Phenylcyclopropyl)methylamines as Novel Serotonin 2C Agonists: Effects on Hyperlocomotion, Prepulse Inhibition, and Cognition Models.

University of Illinois At Chicago
Optimization of 2-phenylcyclopropylmethylamines as selective serotonin 2C receptor agonists and their evaluation as potential antipsychotic agents.

University of Illinois At Chicago
Design, synthesis and evaluation of novel HDAC inhibitors as potential antitumor agents.

Shanghai Huilun Life Sciences & Technology
Synthesis, biological assay in vitro and molecular docking studies of new imidazopyrazinone derivatives as potential dipeptidyl peptidase IV inhibitors.

East China University of Science and Technology
The discovery of CP-96,021 and CP-96,486, balanced, combined, potent and orally active leukotriene D
4 (LTD
4)/platelet activating factor (PAF) receptor antagonists.

TBA
Synthesis and biological evaluation of multimodal monoaminergic arylpiperazine derivatives with potential antidepressant profile.

University of Chinese Academy of Sciences
Discovery of Novel HDAC3 Inhibitors with PD-L1 Downregulating/Degrading and Antitumor Immune Effects.

Southern Medical University
Synthesis and biological evaluation of 4-imidazolidinone-containing compounds as potent inhibitors of the MDM2/p53 interaction.

Nanjing University of Chinese Medicine
Transformation of a Dopamine D

Shanghaitech University
Design and Synthesis of Triazole-Containing HDAC Inhibitors That Induce Antitumor Effects and Immune Response.

Xuzhou Medical University
Discovery of JN122, a Spiroindoline-Containing Molecule that Inhibits MDM2/p53 Protein-Protein Interaction and Exerts Robust In Vivo Antitumor Efficacy.

Shanghai Institute of Materia Medica
A chemical perspective on the modulation of TEAD transcriptional activities: Recent progress, challenges, and opportunities.

Shanghai Institute of Materia Medica
Optical-Controlled Kinetic Switch: Fine-Tuning of the Residence Time of an Antagonist Binding to the Vasopressin V

Xuzhou Medical University
2-Phenylcyclopropylmethylamine (PCPMA) as a privileged scaffold for central nervous system drug design.

Shanghaitech University
Discovery of Highly Potent Nicotinamide Phosphoribosyltransferase Degraders for Efficient Treatment of Ovarian Cancer.

Second Military Medical University
Optimization of P2Y

East China Normal University
Discovery of a Potent FLT3 Inhibitor (LT-850-166) with the Capacity of Overcoming a Variety of FLT3 Mutations.

China Pharmaceutical University
Ispinesib as an Effective Warhead for the Design of Autophagosome-Tethering Chimeras: Discovery of Potent Degraders of Nicotinamide Phosphoribosyltransferase (NAMPT).

Second Military Medical University
Dual-acting antitumor agents targeting the A

Shanghaitech University
Long Residence Time at the Vasopressin V

Xuzhou Medical University
Making Protein Degradation Visible: Discovery of Theranostic PROTACs for Detecting and Degrading NAMPT.

Second Military Medical University (Navy Medical University)
FLT3 Inhibitors in Acute Myeloid Leukemia: Challenges and Recent Developments in Overcoming Resistance.

China Pharmaceutical University
Isothiazolopyridones: synthesis, structure, and biological activity of a new class of antibacterial agents.

Achillion Pharmaceuticals
Isothiazoloquinolones containing functionalized aromatic hydrocarbons at the 7-position: synthesis and in vitro activity of a series of potent antibacterial agents with diminished cytotoxicity in human cells.

Achillion Pharmaceuticals
Biological evaluation of isothiazoloquinolones containing aromatic heterocycles at the 7-position: In vitro activity of a series of potent antibacterial agents that are effective against methicillin-resistant Staphylococcus aureus.

Achillion Pharmaceuticals
Identification and structural analysis of a selective tropomyosin receptor kinase C (TRKC) inhibitor.

China Pharmaceutical University
Carbon-silicon switch led to the discovery of novel synthetic cannabinoids with therapeutic effects in a mouse model of multiple sclerosis.

Shanghaitech University
Identification and In Silico Binding Study of a Highly Potent DENV NS2B-NS3 Covalent Inhibitor.

Shenyang Pharmaceutical University
Hydrophobic Tagging-Induced Degradation of PDEδ in Colon Cancer Cells.

Second Military Medical University
Structure-Based Design of Dual-Acting Compounds Targeting Adenosine A

Shanghaitech University
2-Phenylcyclopropylmethylamine Derivatives as Dopamine D

Shanghaitech University
Structure-Activity Relationship Studies of Coumarin-like Diacid Derivatives as Human G Protein-Coupled Receptor-35 (hGPR35) Agonists and a Consequent New Design Principle.

Chinese Academy of Sciences
Design and Discovery of Functionally Selective Serotonin 2C (5-HT

University of Illinois At Chicago
Discovery of Novel PDEδ Degraders for the Treatment of KRAS Mutant Colorectal Cancer.

Second Military Medical University
Antimycobacterial Rufomycin Analogues from

University of Illinois At Chicago
Development of selective mono or dual PROTAC degrader probe of CDK isoforms.

Sichuan University and Collaborative Innovation Center of Biotherapy
Design and Synthesis of Bitopic 2-Phenylcyclopropylmethylamine (PCPMA) Derivatives as Selective Dopamine D3 Receptor Ligands.

Shanghaitech University
Structure-activity relationships for a class of inhibitors of purine nucleoside phosphorylase.

University of Michigan
Scaffold Hopping of Natural Product Evodiamine: Discovery of a Novel Antitumor Scaffold with Excellent Potency against Colon Cancer.

Second Military Medical University
Biased Ligands of G Protein-Coupled Receptors (GPCRs): Structure-Functional Selectivity Relationships (SFSRs) and Therapeutic Potential.

Shanghaitech University
Design of fluorinated cyclopropane derivatives of 2-phenylcyclopropylmethylamine leading to identification of a selective serotonin 2C (5-HT

University of Illinois At Chicago
Design, synthesis, antitumor activities and biological studies of novel diaryl substituted fused heterocycles as dual ligands targeting tubulin and katanin.

Fudan University
Discovery of 4,6-

Hubei University of Technology
Discovery of Novel Aryl Carboxamide Derivatives as Hypoxia-Inducible Factor 1α Signaling Inhibitors with Potent Activities of Anticancer Metastasis.

Anhui Medical University
Homology modeling and atomic level binding study of GABA(A) receptor with novel enaminone amides.

Wuhan Institute of Technology
Dual targeting of DNA gyrase and topoisomerase IV: target interactions of heteroaryl isothiazolones in Staphylococcus aureus.

Achillion Pharmaceuticals
Isothiazoloquinolones with enhanced antistaphylococcal activities against multidrug-resistant strains: effects of structural modifications at the 6-, 7-, and 8-positions.

Achillion Pharmaceuticals
Synthesis and biological evaluation at nicotinic acetylcholine receptors of N-arylalkyl- and N-aryl-7-azabicyclo[2.2.1]heptanes.

University of New Orleans
b-Annulated 1,4-dihydropyridines as Notch inhibitors.

Human Biomolecular Research Institute
Discovery of novel Syk/PDGFR-α/c-Kit inhibitors as multi-targeting drugs to treat rheumatoid arthritis.

East China University of Science & Technology
Novel tertiary sulfonamides as potent anti-cancer agents.

Human Biomolecular Research Institute
Therapeutically active compounds and their methods of use

Servier Pharmaceuticals
TRIAZOLO WRN INHIBITORS

Nimbus Wadjet
PHOSPHONATES AS INHIBITORS OF ENPP1 AND CDNP

Stingray Therapeutics
3-HYDROXY-5-(ISOXAZOL-5-YL) PYRIDINE FORMYLGLYCINE COMPOUNDS, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE

China Pharmaceutical University
HETEROAROMATIC COMPOUNDS

Astrazeneca
Tertiary amines for use in the treatment of cardiac disorders

Universitetet I Oslo